Q32 Bio to Participate in Upcoming September Investor Conferences
The company will host fireside chats at three healthcare conferences and provide webcast replays for 90 days, according to Q32 Bio.
- Palladyne AI announced that CEO Ben Wolff and CFO Trevor Thatcher will participate in two upcoming investor conferences this September, showcasing the company's embodied AI-powered collaborative autonomy solutions.
- Numerous industry peers, including BridgeBio Pharma, IDEAYA Biosciences, and Editas Medicine, have scheduled executive participation in September investor conferences to discuss their respective development pipelines and therapeutic strategies.
- Gates Industrial Corporation CEO Ivo Jurek and CFO Brooks Mallard will present at the Jefferies Global Industrials Conference on Wednesday, September 9, 2026, at 1:30 p.m. ET.
- Interested investors can access live audio webcasts of these presentations, with archived replays remaining available on corporate websites for up to 90 days following each event.
- These September events provide critical platforms for firms to address market interest in artificial intelligence and biotechnology sectors, as management teams communicate long-term development strategies to investors.
23 Articles
23 Articles
Morgan County Citizen
inovio.comINOVIO to Participate in Upcoming Investor Conferences
PLYMOUTH MEETING, Pa., Sept. 1, 2026 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer and infectious diseases, today announced that it will participate in…
ARS Pharmaceuticals to Participate in Upcoming Investor Conferences
SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to treat and prevent severe allergic reactions, today announced that Donn Casale, President and CEO, will…
North Bay Nipissing
Financial PostProMIS Neurosciences to Participate in Upcoming Conferences and Events in September
CAMBRIDGE, Mass, Sept. 01, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in neurodegenerative diseases, today announced that it will participate in upcoming September 2026 conferences…
BridgeBio to Participate in September Investor Conferences
PALO ALTO, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for genetic conditions, today announced that members of its management team will participate…
Q32 Bio to Participate in Upcoming September Investor Conferences
WALTHAM, Mass., Sept. 1, 2026 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata ("AA") and other autoimmune and inflammatory diseases, today announced that management will participate…
Coverage Details
Bias Distribution
- 63% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
